Back

Factors that increase the risk of hepatocarcinoma in Fontan-associated liver disease (FALD) and new biomarkers of FALD by proteomic analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders Congenital Heart Disease ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Yoshihito Morimoto

National Cerebral & Cardiovascular Center, Suita (Japan)

8 More presentations in this session

Presentation thumbnail
Discussant - Biomarkers, biomechanics, and innovations in valve and vascular disorders
Presentation thumbnail
Benefits of extubation after the Fontan operation: a theoretical analysis using serial patient-specific Fontan computational fluid dynamics models
Doctor K. Sughimoto (Chiba, JP)
Abstract Video
Presentation thumbnail
Patient vascular model reveals anti-inflammatory effects of SGLT2 inhibitor by modulating endothelial-T cell crosstalk
Ms K. Lee (Singapore, SG)
Abstract
Presentation thumbnail
Soluble LOX-1 (lectin-type oxidized LDL receptor 1) is associated with inflammation and mortality in aortic valve stenosis
Doctor M. Al Zaidi (Bonn, DE)
Abstract
Presentation thumbnail
A novel heart valve design reduces turbulence in aortic flow
Doctor S. Zheng (Bern, CH)
Abstract

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Biomarkers, biomechanics, and innovations in valve and vascular disorders

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
A surveillance for advanced liver disease and characterization of hyperechogenic lesions after Fontan surgery in a prospective cohort of cases with congenital univentricular heart.
thumbnail
Congress Presentation
Early detection of liver fibrosis in patients with Fontan circulation using multiparametric magnetic resonance imaging
thumbnail
Congress Presentation
Cardiac secreted-HSP90alpha in cardiomyocyte hypertrophy by N-Cadherin mediated signaling under pressure overload

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources